LiNanlin,Ph.D, Chief Physician,Clinical Professor
1 clinical trials · Sponsor
◉ Watch LiNanlin,Ph.D, Chief Physician,Clinical Professor
| Record | Firm | Date |
|---|---|---|
| Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy (NCT01652560) | LiNanlin,Ph.D, Chief Physician,Clinical Professor | 2012-06-01 |
Track LiNanlin,Ph.D, Chief Physician,Clinical Professor automatically
Every clearance here is in the API, with alerts when new ones post.